Symbol: |
SPG20
|
Description: |
spastic paraplegia 20 (Troyer syndrome) [Source:HGNC Symbol;Acc:18514]
|
Location: |
Chr13:36875775-36944317[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:75
Gene |
Compound |
Gen_sig |
Exp_pattern |
SPG20 |
5-(p-chlorobenzylidene)-3-phenyl-2-[(1-phenyl-3,5- dimethylpyrazol-4-yl)methylidenehydrazono]thiazolidin-4-one |
0.027 |
Up |
SPG20 |
NSC 720187 |
0.025 |
Down |
SPG20 |
NSC 721533 |
0.032 |
Up |
SPG20 |
NSC 721536 |
0.016 |
Up |
SPG20 |
4-[4-(2-Diethylamino-ethylamino)-naphthalen-1-ylazo]-benzene sulfonamide |
0.005 |
Up |
SPG20 |
Pyridone-OCH3 |
0.002 |
Down |
SPG20 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.024 |
Down |
SPG20 |
NSC 733155 |
0.038 |
Up |
SPG20 |
6-(3-Aminopropyl)-5,6-dihbydro-3-nitro-5,11-dioxo-9-phenyl-1 1H[1,2-c]isoquinoline Hydrochloride |
0.014 |
Up |
SPG20 |
6-(11-aminoundecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.029 |
Up |
SPG20 |
Ethylenediaminetetraacetic acid bis-(5-amino salicylic acid methyl ester) |
0.027 |
Down |
SPG20 |
NSC 743399 |
0.029 |
Up |
SPG20 |
2-{4-[4-(4-{4-[6-(4-methyl piperazino)-1H-benzo[d]imidazole-2-yl]phenoxy}butyl)piperazino]butyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione |
0.01 |
Down |
SPG20 |
NSC 743696 |
0.039 |
Up |
SPG20 |
NSC 747199 |
0.025 |
Up |
Expression pattern: Sensitivity / Resistance
Total:5 Current:5
First Prev [Next] [Last]
|
SNP:
~ Export ~
|
Records:34
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:43
Total:3 Current:1
[First] [Prev]  Next Last 
|